Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2019 Filed Mar 28, 2019 19:40 UTC |
Shah Nirav RDirector
|
GrantCareer Restricted Stock Units · Derivative | 1,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021607 · doc4.xml · derivative · entry 1 Shah Nirav R · CIK 0001740213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,743 Underlying: Ordinary Shares · 1,743 shares Expires not disclosed F1 · derivative.exercise_price: These career restricted stock units were assumed by STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), pursuant to a court-approved scheme of arrangement under English law and converted to career restricted stock units of STERIS representing the right to receive 1,743 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F1 · derivative.exercise_date: These career restricted stock units were assumed by STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), pursuant to a court-approved scheme of arrangement under English law and converted to career restricted stock units of STERIS representing the right to receive 1,743 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F1 · derivative.expiration_date: These career restricted stock units were assumed by STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), pursuant to a court-approved scheme of arrangement under English law and converted to career restricted stock units of STERIS representing the right to receive 1,743 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 136,268 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · derivative · entry 7 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,268 Underlying: Ordinary Shares · 136,268 shares Expires 2028-05-31 F8 · price: This option becomes exercisable as follows: 34,067 on May 31, 2019; 34,067 on June 1, 2020; 34,067 on June 1, 2021 and 34,067 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 136,268 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 34,067 on May 31, 2019; 34,067 on June 1, 2020; 34,067 on June 1, 2021 and 34,067 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 136,268 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 136,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · derivative · entry 6 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,000 Underlying: Ordinary Shares · 136,000 shares Expires 2027-05-30 F7 · price: This option becomes exercisable as follows: 34,000 on May 30, 2018; 34,000 on May 30, 2019; 34,000 on June 1, 2020 and 34,000 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 136,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option becomes exercisable as follows: 34,000 on May 30, 2018; 34,000 on May 30, 2019; 34,000 on June 1, 2020 and 34,000 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 136,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 112,340 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · derivative · entry 5 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,340 Underlying: Ordinary Shares · 112,340 shares Expires 2026-06-01 F6 · price: This option becomes exercisable as follows: 28,085 on June 1, 2017; 28,085 on June 1, 2018; 28,085 on June 3, 2019 and 28,085 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 112,340 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 28,085 on June 1, 2017; 28,085 on June 1, 2018; 28,085 on June 3, 2019 and 28,085 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 112,340 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 111,000 | Not disclosed Strike: $67.98 | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · derivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,000 Underlying: Ordinary Shares · 111,000 shares Expires 2025-08-10 F5 · price: This option becomes exercisable as follows: 27,750 on May 28, 2016; 27,750 on May 28, 2017; 27,750 on May 28, 2018 and 27,750 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 111,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option becomes exercisable as follows: 27,750 on May 28, 2016; 27,750 on May 28, 2017; 27,750 on May 28, 2018 and 27,750 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 111,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 119,000 | Not disclosed Strike: $53.52 | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · derivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,000 Underlying: Ordinary Shares · 119,000 shares Expires 2024-05-30 F4 · price: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option F4 · derivative.exercise_date: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
GrantOrdinary Shares | 13,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 13,000 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3 · ownership.nature: These ordinary shares are held by the reporting person's spouse as trustee of a revocable trust established for her benefit. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
GrantOrdinary Shares | 48,895 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,895 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2 · balance_after: These 48,895 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 37,375 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,625 on May 28, 2019; 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:34 UTC |
Nichol Duncan KDirector
|
GrantCareer Restricted Stock Units · Derivative | 5,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021605 · doc4.xml · derivative · entry 1 Nichol Duncan K · CIK 0001656937 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,662 Underlying: Ordinary Shares · 5,662 shares Expires not disclosed F1 · derivative.exercise_price: These career restricted stock units were assumed by STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), pursuant to a court-approved scheme of arrangement under English law and converted to career restricted stock units of STERIS representing the right to receive 5,662 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F1 · derivative.exercise_date: These career restricted stock units were assumed by STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), pursuant to a court-approved scheme of arrangement under English law and converted to career restricted stock units of STERIS representing the right to receive 5,662 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F1 · derivative.expiration_date: These career restricted stock units were assumed by STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), pursuant to a court-approved scheme of arrangement under English law and converted to career restricted stock units of STERIS representing the right to receive 5,662 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantCareer Restricted Stock Units · Derivative | 3,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 12 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,184 Underlying: Ordinary Shares · 3,184 shares Expires not disclosed F13 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F13 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F13 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 436 | Not disclosed Strike: $114.74 | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 11 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436 Underlying: Ordinary Shares · 436 shares Expires 2028-08-09 F12 · price: This option to purchase 436 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 436 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. F12 · derivative.exercise_date: This option to purchase 436 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 436 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 927 | Not disclosed Strike: $86.23 | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 10 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 927 Underlying: Ordinary Shares · 927 shares Expires 2027-08-09 F11 · price: This option to purchase 927 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 927 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. F11 · derivative.exercise_date: This option to purchase 927 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 927 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,781 | Not disclosed Strike: $71.40 | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 9 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,781 Underlying: Ordinary Shares · 3,781 shares Expires 2026-08-10 F10 · price: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. F10 · derivative.exercise_date: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,110 | Not disclosed Strike: $64.05 | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 8 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,110 Underlying: Ordinary Shares · 4,110 shares Expires 2025-08-31 F9 · price: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. F9 · derivative.exercise_date: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,584 | Not disclosed Strike: $51.53 | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 7 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,584 Underlying: Ordinary Shares · 4,584 shares Expires 2024-08-06 F8 · price: This option to purchase 4,584 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,584 Old STERIS ordinary shares for $51.53 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option to purchase 4,584 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,584 Old STERIS ordinary shares for $51.53 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,657 | Not disclosed Strike: $43.92 | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 6 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,657 Underlying: Ordinary Shares · 4,657 shares Expires 2023-08-08 F7 · price: This option to purchase 4,657 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,657 Old STERIS ordinary shares for $43.92 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option to purchase 4,657 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,657 Old STERIS ordinary shares for $43.92 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,218 | Not disclosed Strike: $32.36 | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 5 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 F6 · price: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,121 | Not disclosed Strike: $31.61 | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,121 Underlying: Ordinary Shares · 3,121 shares Expires 2021-08-03 F5 · price: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,133 | Not disclosed Strike: $32.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,133 Underlying: Ordinary Shares · 3,133 shares Expires 2020-08-04 F4 · price: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,609 | Not disclosed Strike: $28.08 | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,609 Underlying: Ordinary Shares · 3,609 shares Expires 2019-07-31 F3 · price: This option to purchase 3,609 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,609 Old STERIS ordinary shares for $28.08 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option to purchase 3,609 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,609 Old STERIS ordinary shares for $28.08 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantOrdinary Shares | 42,830 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 42,830 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2 · ownership.nature: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:28 UTC |
Khan Gulam AmjadSr. V.P., Procedural Solutions
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,536 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021602 · doc4.xml · derivative · entry 5 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,536 Underlying: Ordinary Shares · 20,536 shares Expires 2028-05-31 F6 · price: This option becomes exercisable as follows: 5,134 on May 31, 2019; 5,134 on June 1, 2020; 5,134 on June 1, 2021 and 5,134 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 20,536 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 5,134 on May 31, 2019; 5,134 on June 1, 2020; 5,134 on June 1, 2021 and 5,134 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 20,536 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:28 UTC |
Khan Gulam AmjadSr. V.P., Procedural Solutions
|
GrantEmployee Stock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021602 · doc4.xml · derivative · entry 4 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2027-05-30 F5 · price: This option becomes exercisable as follows: 3,750 on May 30, 2018;3,750 on May 30, 2019; 3,750 on June 1, 2020 and 3,750 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option becomes exercisable as follows: 3,750 on May 30, 2018;3,750 on May 30, 2019; 3,750 on June 1, 2020 and 3,750 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:28 UTC |
Khan Gulam AmjadSr. V.P., Procedural Solutions
|
GrantEmployee Stock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021602 · doc4.xml · derivative · entry 3 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2026-06-01 F4 · price: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:28 UTC |
Khan Gulam AmjadSr. V.P., Procedural Solutions
|
GrantEmployee Stock Option (right to buy) · Derivative | 11,700 | Not disclosed Strike: $65.05 | Not disclosed |
DisclosureSEC source: 0001209191-19-021602 · doc4.xml · derivative · entry 2 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,700 Underlying: Ordinary Shares · 11,700 shares Expires 2025-08-27 F3 · price: This option become exercisable as follows: 2,925 on May 28, 2016; 2,925 on May 28, 2017; 2,925 on May 28, 2018 and 2,925 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 11,700 STERIS ordinary shares for $65.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option become exercisable as follows: 2,925 on May 28, 2016; 2,925 on May 28, 2017; 2,925 on May 28, 2018 and 2,925 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 11,700 STERIS ordinary shares for $65.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:28 UTC |
Khan Gulam AmjadSr. V.P., Procedural Solutions
|
GrantOrdinary Shares | 15,864 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021602 · doc4.xml · nonDerivative · entry 1 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,864 F1 · shares: All 15,864 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 2,500 on June 1, 2020; 4,500 on June 1, 2021 and 1,864 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F1 · balance_after: All 15,864 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 2,500 on June 1, 2020; 4,500 on June 1, 2021 and 1,864 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:05 UTC |
FELDMANN CYNTHIA LDirector
|
GrantCareer Restricted Stock Units · Derivative | 5,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021601 · doc4.xml · derivative · entry 6 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,449 Underlying: Ordinary Shares · 5,449 shares Expires not disclosed F7 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to a the Scheme and converted to career restricted stock units of STERIS representing the right to receive 5,449 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F7 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to a the Scheme and converted to career restricted stock units of STERIS representing the right to receive 5,449 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F7 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to a the Scheme and converted to career restricted stock units of STERIS representing the right to receive 5,449 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:05 UTC |
FELDMANN CYNTHIA LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,495 | Not disclosed Strike: $114.74 | Not disclosed |
DisclosureSEC source: 0001209191-19-021601 · doc4.xml · derivative · entry 5 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,495 Underlying: Ordinary Shares · 3,495 shares Expires 2028-08-09 F6 · price: This option to purchase 3,495 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,495 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option to purchase 3,495 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,495 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:05 UTC |
FELDMANN CYNTHIA LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,058 | Not disclosed Strike: $86.23 | Not disclosed |
DisclosureSEC source: 0001209191-19-021601 · doc4.xml · derivative · entry 4 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,058 Underlying: Ordinary Shares · 4,058 shares Expires 2027-08-09 F5 · price: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:05 UTC |
FELDMANN CYNTHIA LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,781 | Not disclosed Strike: $71.40 | Not disclosed |
DisclosureSEC source: 0001209191-19-021601 · doc4.xml · derivative · entry 3 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,781 Underlying: Ordinary Shares · 3,781 shares Expires 2026-08-10 F4 · price: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:05 UTC |
FELDMANN CYNTHIA LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,110 | Not disclosed Strike: $64.05 | Not disclosed |
DisclosureSEC source: 0001209191-19-021601 · doc4.xml · derivative · entry 2 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,110 Underlying: Ordinary Shares · 4,110 shares Expires 2025-08-31 F3 · price: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:05 UTC |
FELDMANN CYNTHIA LDirector
|
GrantOrdinary Shares | 8,663 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021601 · doc4.xml · nonDerivative · entry 1 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 8,663 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2 · ownership.nature: These ordinary shares are held in the Cynthia L. Feldman Revocable Trust, with Ms. Feldman and her husband as Trustees. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:02 UTC |
deZwaan MichielV.P., Human Resources & CHRO
|
GrantEmployee Stock Option (right to buy) · Derivative | 14,932 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021600 · doc4.xml · derivative · entry 2 deZwaan Michiel · CIK 0001616395 · V.P., Human Resources & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,932 Underlying: Ordinary Shares · 14,932 shares Expires 2028-05-31 F3 · price: This option becomes exercisable as follows: 3,733 on May 31, 2019; 3,733 on June 1, 2020; 3,733 on June 1, 2021 and 3,733 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 14,932 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option becomes exercisable as follows: 3,733 on May 31, 2019; 3,733 on June 1, 2020; 3,733 on June 1, 2021 and 3,733 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 14,932 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:02 UTC |
deZwaan MichielV.P., Human Resources & CHRO
|
GrantOrdinary Shares | 5,898 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021600 · doc4.xml · nonDerivative · entry 1 deZwaan Michiel · CIK 0001616395 · V.P., Human Resources & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,898 F1 · shares: All 5,898 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,378 on October 4, 2021 and 2,520 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F1 · balance_after: All 5,898 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,378 on October 4, 2021 and 2,520 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:00 UTC |
Coward Adrian VincentSr. V P, Healthcare Spec Serv
|
GrantEmployee Stock Option (right to buy) · Derivative | 15,680 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021599 · doc4.xml · derivative · entry 3 Coward Adrian Vincent · CIK 0001657350 · Sr. V P, Healthcare Spec Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,680 Underlying: Ordinary Shares · 15,680 shares Expires 2028-05-31 F4 · price: This option becomes exercisable as follows: 3,920 on May 31, 2019; 3,920 on June 1, 2020; 3,920 on June 1, 2021 and 3,920 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 15,680 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option becomes exercisable as follows: 3,920 on May 31, 2019; 3,920 on June 1, 2020; 3,920 on June 1, 2021 and 3,920 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 15,680 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:00 UTC |
Coward Adrian VincentSr. V P, Healthcare Spec Serv
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021599 · doc4.xml · derivative · entry 2 Coward Adrian Vincent · CIK 0001657350 · Sr. V P, Healthcare Spec Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2027-05-30 F3 · price: This option becomes exercisable as follows: 2,500 on May 30, 2018; 2,500 on May 30, 2019; 2,500 on June 1, 2020 and 2,500 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 10,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option becomes exercisable as follows: 2,500 on May 30, 2018; 2,500 on May 30, 2019; 2,500 on June 1, 2020 and 2,500 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 10,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:00 UTC |
Coward Adrian VincentSr. V P, Healthcare Spec Serv
|
GrantOrdinary Shares | 23,823 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021599 · doc4.xml · nonDerivative · entry 1 Coward Adrian Vincent · CIK 0001657350 · Sr. V P, Healthcare Spec Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,823 F1 · shares: 10,452 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,028 on October 1, 2019; 3,000 on June 1, 2021 and 1,424 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F1 · balance_after: 10,452 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,028 on October 1, 2019; 3,000 on June 1, 2021 and 1,424 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 18:59 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
GrantEmployee Stock Option (right to buy) · Derivative | 9,468 | Not disclosed Strike: $125.58 | Not disclosed |
DisclosureSEC source: 0001209191-19-021598 · doc4.xml · derivative · entry 7 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,468 Underlying: Ordinary Shares · 9,468 shares Expires 2028-10-01 F8 · price: This option becomes exercisable as follows: 2,367 shares on October 1, 2019; 2,367 shares on October 1, 2020; 2,367 shares on October 1, 2021 and 2,367 shares on October 3, 2022. This option was received under the Scheme in exchange for an option to purchase 9,468 STERIS ordinary shares for $125.58 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 2,367 shares on October 1, 2019; 2,367 shares on October 1, 2020; 2,367 shares on October 1, 2021 and 2,367 shares on October 3, 2022. This option was received under the Scheme in exchange for an option to purchase 9,468 STERIS ordinary shares for $125.58 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 18:59 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
GrantEmployee Stock Option (right to buy) · Derivative | 29,864 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021598 · doc4.xml · derivative · entry 6 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,864 Underlying: Ordinary Shares · 29,864 shares Expires 2028-05-31 F7 · price: This option becomes exercisable as follows: 7,466 on May 31, 2019; 7,466 on June 1, 2020; 7,466 on June 1, 2021 and 7,466 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 29,864 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option becomes exercisable as follows: 7,466 on May 31, 2019; 7,466 on June 1, 2020; 7,466 on June 1, 2021 and 7,466 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 29,864 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 18:59 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
GrantEmployee Stock Option (right to buy) · Derivative | 18,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021598 · doc4.xml · derivative · entry 5 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Ordinary Shares · 18,000 shares Expires 2027-05-30 F6 · price: This option becomes exercisable as follows: 4,500 on May 30, 2018; 4,500 on May 30, 2019; 4,500 on June 1, 2020 and 4,500 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 18,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 4,500 on May 30, 2018; 4,500 on May 30, 2019; 4,500 on June 1, 2020 and 4,500 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 18,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 18:59 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
GrantEmployee Stock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021598 · doc4.xml · derivative · entry 4 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2026-06-01 F5 · price: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F5 · derivative.exercise_date: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 18:59 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,000 | Not disclosed Strike: $67.98 | Not disclosed |
DisclosureSEC source: 0001209191-19-021598 · doc4.xml · derivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Ordinary Shares · 8,000 shares Expires 2025-08-10 F4 · price: This option becomes exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 8,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option becomes exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 8,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 18:59 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,000 | Not disclosed Strike: $53.52 | Not disclosed |
DisclosureSEC source: 0001209191-19-021598 · doc4.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Ordinary Shares · 7,000 shares Expires 2024-05-30 F3 · price: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option F3 · derivative.exercise_date: This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 18:59 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
GrantOrdinary Shares | 20,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021598 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,460 F1 · shares: 20,460 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022 and 1,748 on October 3, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F1 · balance_after: 20,460 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022 and 1,748 on October 3, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 18:57 UTC |
Burton Karen LVP, Controller & CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,900 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021597 · doc4.xml · derivative · entry 9 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Ordinary Shares · 7,900 shares Expires 2028-05-31 F10 · price: This option becomes exercisable as follows: 1,975 on May 31, 2019; 1,975 on June 1, 2020; 1,975 on June 1, 2021 and 1,975 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 7.900 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F10 · derivative.exercise_date: This option becomes exercisable as follows: 1,975 on May 31, 2019; 1,975 on June 1, 2020; 1,975 on June 1, 2021 and 1,975 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 7.900 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 18:57 UTC |
Burton Karen LVP, Controller & CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 4,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021597 · doc4.xml · derivative · entry 8 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Ordinary Shares · 4,000 shares Expires 2027-05-30 F9 · price: This option becomes exercisable as follows: 1,000 on May 30, 2018; 1,000 on May 30, 2019; 1,000 on June 1, 2020 and 1,000 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 4,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. F9 · derivative.exercise_date: This option becomes exercisable as follows: 1,000 on May 30, 2018; 1,000 on May 30, 2019; 1,000 on June 1, 2020 and 1,000 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 4,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 18:57 UTC |
Burton Karen LVP, Controller & CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,600 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021597 · doc4.xml · derivative · entry 7 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Underlying: Ordinary Shares · 2,600 shares Expires 2026-06-01 F8 · price: This option becomes exercisable as follows: 650 on June 1, 2017; 650 on June 1, 2018; 650 on June 3, 2019 and 650 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 2,600 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 650 on June 1, 2017; 650 on June 1, 2018; 650 on June 3, 2019 and 650 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 2,600 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 18:57 UTC |
Burton Karen LVP, Controller & CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,852 | Not disclosed Strike: $66.15 | Not disclosed |
DisclosureSEC source: 0001209191-19-021597 · doc4.xml · derivative · entry 6 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,852 Underlying: Ordinary Shares · 2,852 shares Expires 2025-05-28 F7 · price: This option becomes exercisable as follows: 713 on May 28, 2016, 713 on May 30, 2017, 713 on May 29, 2018 and 713 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 2,852 STERIS ordinary shares for $66.15 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option becomes exercisable as follows: 713 on May 28, 2016, 713 on May 30, 2017, 713 on May 29, 2018 and 713 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 2,852 STERIS ordinary shares for $66.15 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 18:57 UTC |
Burton Karen LVP, Controller & CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,400 | Not disclosed Strike: $53.52 | Not disclosed |
DisclosureSEC source: 0001209191-19-021597 · doc4.xml · derivative · entry 5 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,400 Underlying: Ordinary Shares · 3,400 shares Expires 2024-05-30 F6 · price: This option to purchase 3,400 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,400 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option to purchase 3,400 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,400 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 18:57 UTC |
Burton Karen LVP, Controller & CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 4,040 | Not disclosed Strike: $45.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021597 · doc4.xml · derivative · entry 4 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,040 Underlying: Ordinary Shares · 4,040 shares Expires 2023-05-31 F5 · price: This option to purchase 4,040 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,040 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option to purchase 4,040 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,040 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.